KisoTerra Biotech Corp. — Form D
KisoTerra Biotech Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-07. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Other.
Offering
- Filed: 2021-07-07
- Form: D
- Accession: 0001062993-21-006377
- Industry: Other
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 12
- Date of first sale: 2021-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405476
Issuer
- Name: KisoTerra Biotech Corp.
- CIK: 0001754473
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2017
- Address: 1090 HOMER STREET, VANCOUVER, A1, V6B 2W9
- Phone: 6042606944
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| John Johnston | Director | Chicago, IL |
| Lawrence Lund | Director | Smithers, A1 |
| John Johnston | Executive Officer | Chicago, IL |
| Lawrence Lund | Executive Officer | Smithers, A1 |
| Josef Reschreiter | Director | Vancouver, A1 |
| Josef Reschreiter | Executive Officer | Vancouver, A1 |
| Rich Frontain | Director | Vancouver, A1 |
| David Work | Director | Vancouver, A1 |
| Michael Stocker | Director | Vancouver, A1 |
| Michael Stocker | Executive Officer | Vancouver, A1 |
| Neil Branda | Director | Vancouver, A1 |
| Neil Branda | Executive Officer | Vancouver, A1 |
| Dirk Lange | Director | Vancouver, A1 |
| Dirk Lange | Executive Officer | Vancouver, A1 |
| Brent Hunter | Executive Officer | Vancouver, A1 |
| Douglas Frankiw | Director | Vancouver, A1 |
| Dave Work | Director | CHILLIWACK, A1 |
| Dave Work | Executive Officer | CHILLIWACK, A1 |
| Kenneth Philippe | Executive Officer | CHILLIWACK, A1 |
| Daniel Hunter | Director | CHILLIWACK, A1 |
| Daniel Hunter | Executive Officer | CHILLIWACK, A1 |
Other filings by this issuer (6)
More